Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Antitumor Effect of Soluble ${\beta}$-1,3-Glucan from Agrobacterium sp. R259 KCTC 1019

  • Shim, Jung-Hyun (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Sung, Ki-Joong (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Cho, Min-Chul (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Choi, Won-A (DMJ Biotech Corp.) ;
  • Yang, Young (Department of Biological Sciences, Research Center for Women's Diseases, Sookmyung Womens's University) ;
  • Lim, Jong-Seok (Department of Biological Sciences, Research Center for Women's Diseases, Sookmyung Womens's University) ;
  • Yoon, Do-Young (Department of Bioscience and Biotechnology, Konkuk University)
  • Published : 2007.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

[ ${\beta}$ ]-1,3-Glucans enhance immune reactions such as antitumor, antibacterial, antiviral, anticoagulatory, and wound healing activities. ${\beta}$-1,3-Glucans have various functions depending on the molecular weight, degree of branching, conformation, water solubility, and intermolecular association. The molecular weight of the soluble glucan was about 15,000 as determined by a high-performance size exclusion chromatography. From the infrared (IR) and $^{13}C$ NMR analytical data, the purified soluble glucan was found to exclusively consist of ${\beta}$-D-glucopyranose with 1,3 linkage. We tested the immunestimulating activities of the soluble ${\beta}$-1,3-glucan extracted from Agrobacterium sp. R259 KCTC 1019 and confirmed the following activities. IFN-$_{\gamma}$ and each cytokines were induced in the spleens and thymus of mice treated with soluble ${\beta}$-1,3-glucan. Adjuvant effect was observed on antibody production. Nitric oxide was synthesized in monocytic cell lines treated with ${\beta}$-1,3-glucan. The cytotoxic and antitumor effects were observed on various cancer cell lines and ICR mice. These results strongly suggested that this soluble ${\beta}$-1,3-glucan could be a good candidate for an immune-modulating agent.

Keywords

References

  1. Bohn, J. and J. BeMiller. 1995. $(1{\rightarrow}3)-{\beta}$-Glucans as biological response modifiers: A review of structurefunctional activity relationships. Carbohydr. Polym. 28: 3-14 https://doi.org/10.1016/0144-8617(95)00076-3
  2. Cheung, N., S. Modak, A. Vickers, and B. Knuckles. 2002. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 51: 557-564
  3. Chihara, G. 1992. Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev. Biol. Stand. 77: 191-197
  4. Cho, Y., J. Cho, K. Lee, S. Park, and D. Yoon. 2000. Development of screening systems for drugs against human papillomavirus-associated cervical cancer: Based on E6-E6AP binding. Antiviral Res. 47: 199-206 https://doi.org/10.1016/S0166-3542(00)00109-1
  5. Colle, J., P. Falanga, M. Singer, B. Hevin, and G. Milon. 1997. Quantitation of messenger RNA by competitive RTPCR: A simplified read out assay. J. Immunol. Methods 210: 175-184 https://doi.org/10.1016/S0022-1759(97)00186-5
  6. Di Luzio, N. 1985. Update on the immunomodulating activities of glucans. Springer Semin. Immunopathol. 8: 387-400
  7. Fujimoto, S. 1989. Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer. Nippon Geka Gakkai Zasshi 90: 1447-1450
  8. Ha, C. H., C. W. Yun, H. D. Paik, S. W. Kim, C. W. Kang, H. J. Hwang, and H. I. Chang. 2006. Preparation and analysis of yeast cell wall mannoproteins, immune enhancing materials, from cell wall mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 247-255
  9. Ha, C. H., K. Lim, S. Jang, C. Yun, H. Paik, S. Kim, C. Kang, and H. Chang. 2006. Immune-enhancing alkali-soluble glucans produced by wild-type and mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 576-583
  10. Harada, T., N. Miura, Y. Adachi, M. Nakajima, T. Yadomae, and N. Ohno. 2002. IFN-gamma induction by SCG, 1,3- beta-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. J. Interferon Cytokine Res. 22: 1227-1239 https://doi.org/10.1089/10799900260475759
  11. Hong, K., K. Jang, J. Lee, S. Kim, M. Kim, I. Lee, S. Kim, Y. Lim, and S. Kang. 2005. Bacterial $\beta$-glucan exhibits potent hypoglycemic activity via decrease of serum lipids and adiposity, and increase of UCP mRNA expression. J. Microbiol. Biotechnol. 15: 823-830
  12. Kim, M., K. Ryu, W. Choi, Y. Rhee, and I. Lee. 2003. Enhanced production of (1,3)-$\beta$-D-glucan by a mutant strain of Agrobacterium sp. Biochem. Eng. J. 16: 163-168 https://doi.org/10.1016/S1369-703X(03)00032-9
  13. Kondo, Y., A. Kato, H. Hojo, S. Nozoe, M. Takeuchi, and K. Ochi. 1992. Cytokine-related immunopotentiating activities of paramylon, a beta-(1->3)-D-glucan from Euglena gracilis. J. Pharmacobiodyn. 15: 617-621 https://doi.org/10.1248/bpb1978.15.617
  14. Migliorini, P., G. Corradin, and S. Corradin. 1991. Macrophage $NO_2$-production as a sensitive and rapid assay for the quantitation of murine IFN-$\gamma$. J. Immunol. Methods 139: 107-114 https://doi.org/10.1016/0022-1759(91)90357-L
  15. Mohagheghpour, N., M. Dawson, P. Hobbs, A. Judd, and R. Winant. 1995. Glucans as immunological adjuvants. Adv. Exp. Med. Biol. 383: 13-22
  16. Nathan, C., H. Murray, M. Wiebe, and B. Rubin. 1983. Identification of interferon-gamma as the the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689 https://doi.org/10.1084/jem.158.3.670
  17. Nemoto, J., N. Ohno, K. Saito, Y. Adachi, and T. Yadomae. 1994. Analysis of cytokine mRNAs induced by the administration of a highly branched (1-->3)-beta-D-glucan, OL-2. Biol. Pharm. Bull. 17: 948-954 https://doi.org/10.1248/bpb.17.948
  18. Nicola, N. and D. Hilton. 1998. General classes and functions of four-helix bundle cytokines. Adv. Protein Chem. 52: 1-65 https://doi.org/10.1016/S0065-3233(08)60432-5
  19. Oka, M., S. Hazama, M. Suzuki, F. Wang, and K. Wadamori. 1996. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int. J. Immunopharmacol. 18: 211-216 https://doi.org/10.1016/0192-0561(95)00115-8
  20. Onozaki, K., K. Matsushima, and B. Aggarwal. 1985. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135: 3962-3968
  21. Onozaki, K., K. Matsushima, E. Kleinerman, T. Saito, and J. Oppenheim. 1985. Role of interleukin-1 in promoting human monocyte-mediated tumor cytotoxicity. J. Immunol. 135: 314-320
  22. Raveh, D., B. Kruskal, J. Farland, and R. Ezekowitz. 1998. Th1 and Th2 cytokines cooperate to stimulate mannose-receptormediated phagocytosis. J. Leukocyte Biol. 64: 108-113 https://doi.org/10.1002/jlb.64.1.108
  23. Reizenstein, P. and G. Mathe. 1984. Immunomodulating agent. Immunol. Ser. 35: 347
  24. Rios-Hernandez, M., N. Dos-Santos, Silvia-Cardosa, J. Bello-Garciga, and M. Pedroso. 1994. Immunopharmacological studies of beta-1,3-glucan. Arch. Med. Res. 25: 175-180
  25. Seljeled, R., J. Bogwald, and A. Lundwall. 1981. Glycan stimulation of macrophages in vitro. Exp. Cell Res. 131: 121-129 https://doi.org/10.1016/0014-4827(81)90413-4
  26. Sonn, C., H. Yoon, I. Seong, M. Chang, Y. Kim, H. Kang, S. Suh, and Y. Kim. 2006. MethA fibrosarcoma cells expressing membrane-bound forms of IL-2 enhance antitumor immunity. J. Microbiol. Biotechnol. 16: 1919-1927
  27. Suda, M., N. Ohno, Y. Adachi, and T. Yadomae. 1995. Modulation of the antitumor effect and tissue distribution of highly branched (1->3)-beta-D-glucan, SSG, by carrageenan. Biol. Pharm. Bull. 18: 772-775 https://doi.org/10.1248/bpb.18.772
  28. Taga, T. and T. Kishimoto. 1997. GP130 and the interleukin- 6 family of cytokines. Annu. Rev. Immunol. 15: 797-819 https://doi.org/10.1146/annurev.immunol.15.1.797
  29. Taguchi, T., Y. Kaneko, and G. Chihara. 1988. Lentinan. Biotherapy 2: 509
  30. Tokunaka, K., N. Ohno, Y. Adachi, S. Tanaka, and H. Tamura. 2000. Immunopharmacological and immunotoxicological activities of a water-soluble (1->3)-beta-D-glucan, CSBG, from Candida spp. Int. J. Immunopharmacol. 22: 383-394 https://doi.org/10.1016/S0192-0561(99)00093-4
  31. Tsuzuki, A., T. Tateishi, N. Ohno, Y. Adachi, and T. Yadomae. 1999. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1->3)- beta-D-glucan preparation, sonifilan, in cyclophosphamideinduced leukopenic mice. Biosci. Biotechnol. Biochem. 63: 104-110 https://doi.org/10.1271/bbb.63.104
  32. Wasser, S. 2002. Medicinal mushrooms as a source of antitumor and immuno-modulating polysaccharides. Appl. Microbiol. Biotechnol. 60: 258-274 https://doi.org/10.1007/s00253-002-1076-7
  33. Williams, D., H. Pretus, R. McNamee, E. Jones, H. Ensley, I. Browder, and N. Di Luzio. 1991. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. Immunopharmacology 22: 139-155 https://doi.org/10.1016/0162-3109(91)90039-2